{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:09:28Z","timestamp":1761718168288,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.surg.2010.11.014","type":"journal-article","created":{"date-parts":[[2011,2,6]],"date-time":"2011-02-06T04:09:59Z","timestamp":1296965399000},"page":"484-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice"],"prefix":"10.1016","volume":"149","author":[{"given":"Shi-He","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Smyth-Templeton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikiforos","family":"Ballian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Charles","family":"Brunicardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2010.11.014_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1072-7515(99)00075-7","article-title":"Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database","volume":"189","author":"Sener","year":"1999","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2010.11.014_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ejca.2003.10.026","article-title":"Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients","volume":"40","author":"Kuhlmann","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2010.11.014_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.surg.2010.11.014_bib4","first-page":"27","article-title":"Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance","volume":"26","author":"Prince","year":"1998","journal-title":"Exp Hematol"},{"key":"10.1016\/j.surg.2010.11.014_bib5","first-page":"4208","article-title":"Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines","volume":"5","author":"Pearson","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2010.11.014_bib6","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0959-8049(02)00131-4","article-title":"The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells","volume":"38","author":"Kim","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2010.11.014_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/10430340152712647","article-title":"Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions","volume":"13","author":"Crystal","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2007.06.012","article-title":"Innate immune response induced by gene delivery vectors","volume":"354","author":"Sakurai","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.surg.2010.11.014_bib9","first-page":"56","article-title":"Suppression of pancreatic tumor progression by systemic delivery of a pancreatic-cancer-specific promoter driven Bik mutant","volume":"236","author":"Li","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.surg.2010.11.014_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jgm.701","article-title":"Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy","volume":"7","author":"Deharvengt","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.surg.2010.11.014_bib11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00268-005-0688-3","article-title":"Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes","volume":"30","author":"Wang","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2010.11.014_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2006.04.039","article-title":"Enhanced cytotoxicity of RIPTK gene therapy of pancreatic cancer via PDX-1 co-delivery","volume":"137","author":"Liu","year":"2007","journal-title":"J Surg Res"},{"key":"10.1016\/j.surg.2010.11.014_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jss.2007.02.041","article-title":"Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK\/GCV gene therapy","volume":"141","author":"Liu","year":"2007","journal-title":"J Surg Res"},{"key":"10.1016\/j.surg.2010.11.014_bib14","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1074\/jbc.272.10.6479","article-title":"Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo","volume":"272","author":"Fasbender","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.surg.2010.11.014_bib15","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1089\/hum.1998.9.17-2493","article-title":"Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells","volume":"9","author":"Byk","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib16","first-page":"1653","article-title":"Cationic liposome-enhanced adenoviral gene transfer in a murine head and neck cancer model","volume":"20","author":"Sung","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.surg.2010.11.014_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00004647-200109000-00010","article-title":"Cationic polymer and lipids augment adenovirus-mediated gene transfer to cerebral arteries in vivo","volume":"21","author":"Toyoda","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.surg.2010.11.014_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.joms.2008.06.079","article-title":"Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia","volume":"67","author":"Zhang","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.surg.2010.11.014_bib19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0360-3016(01)01698-4","article-title":"Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model","volume":"51","author":"Vlachaki","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.surg.2010.11.014_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1349-7006.2006.00206.x","article-title":"Phase I\/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma","volume":"97","author":"Shimada","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.surg.2010.11.014_bib21","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1200\/JCO.2003.09.138","article-title":"Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy","volume":"21","author":"Pagliaro","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2010.11.014_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/mt.2008.124","article-title":"Repeat administration of proteins to the eye with a single intraocular injection of an adenovirus vector","volume":"16","author":"McVey","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib23","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0003-4975(00)01815-4","article-title":"Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model","volume":"70","author":"Lambright","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.surg.2010.11.014_bib24","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2005.03.4116","article-title":"Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer","volume":"24","author":"Fujiwara","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2010.11.014_bib25","doi-asserted-by":"crossref","first-page":"9514","DOI":"10.1128\/JVI.72.12.9514-9525.1998","article-title":"Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha","volume":"72","author":"Benihoud","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.surg.2010.11.014_bib26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1124\/jpet.104.071464","article-title":"Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats","volume":"311","author":"Deng","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ejps.2006.12.004","article-title":"Increased tumor localization and reduced immune response to adenoviral vector formulated with the liposome DDAB\/DOPE","volume":"30","author":"Steel","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.surg.2010.11.014_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00432-003-0521-z","article-title":"Liposome-complexed adenoviral gene transfer in cancer cells expressing various levels of coxsackievirus and adenovirus receptor","volume":"130","author":"Lee","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.surg.2010.11.014_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MPA.0b013e31816a4a33","article-title":"PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer","volume":"37","author":"Liu","year":"2008","journal-title":"Pancreas"},{"key":"10.1016\/j.surg.2010.11.014_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000145981","article-title":"Adenoviral gene therapy for pancreatic cancer: where do we stand?","volume":"25","author":"Kuhlmann","year":"2008","journal-title":"Dig Surg"},{"key":"10.1016\/j.surg.2010.11.014_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000125581","article-title":"Adenovirus vectors for renal-targeted gene delivery","volume":"159","author":"Appledorn","year":"2008","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.surg.2010.11.014_bib32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s00268-004-7291-x","article-title":"Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy","volume":"28","author":"Tirone","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2010.11.014_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1067\/mob.2000.104837","article-title":"Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model","volume":"182","author":"Al-Hendy","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.surg.2010.11.014_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.1997.8.1-99","article-title":"Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype","volume":"8","author":"Mack","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib35","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update on adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.surg.2010.11.014_bib36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.gt.3300665","article-title":"Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro","volume":"5","author":"Chillon","year":"1998","journal-title":"Gene Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo","volume":"10","author":"O\u2019Riordan","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1349-7006.2000.tb00953.x","article-title":"Cationic liposome conjugation to recombinant adenoviral vector reduces viral antigenicity","volume":"91","author":"Natsume","year":"2000","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.surg.2010.11.014_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/mthe.1999.0013","article-title":"Free cholesterol enhances adenoviral vector gene transfer and expression in CAR-deficient cells","volume":"1","author":"Worgall","year":"2000","journal-title":"Mol Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib40","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1089\/104303402760372972","article-title":"PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver","volume":"13","author":"Croyle","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.cgt.7700503","article-title":"Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models","volume":"9","author":"Mizuno","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/mthe.2002.0545","article-title":"Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses","volume":"5","author":"Yotnda","year":"2002","journal-title":"Mol Ther"},{"key":"10.1016\/j.surg.2010.11.014_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ymthe.2004.01.018","article-title":"Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids","volume":"9","author":"Yotnda","year":"2004","journal-title":"Mol Ther"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606010006483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606010006483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:48:42Z","timestamp":1758538122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606010006483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0039606010006483"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2010.11.014","relation":{},"ISSN":["0039-6060"],"issn-type":[{"type":"print","value":"0039-6060"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2010.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}